Jiangxi Qingfeng Pharmaceutical Co. Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Jiangxi Qingfeng Pharmaceutical Co. Ltd.
RECRUITINGPhase 3NCT06573008
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
This study will evaluate the efficacy, safety, and population pharmacokinetics of a single, oral dose of GP681 compared with placebo in patients aged 12 and older With Influenza...
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.Enrolling: 3281 location
Influenza, Human
RECRUITINGPhase 3NCT06574503
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
Index patients who are infected with influenza virus (Q-PCR positive) can be treated with anti-influenza drugs if their influenza symptoms onset was within 48 hours of screening....
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.Enrolling: 7481 location
Influenza